What according to you are the key objectives of the BioE3 policy and how is it going to boost the industrial sector in the country?
The BioE3 (Biotechnology for Economy, Environment, and Employment) Policy aims to position India as a leader in bio-manufacturing and address critical challenges like climate change and resource sustainability. Its main objectives include increasing Research and Innovation, Strengthening Domestic Bio-manufacturing, Promoting AI and Digital Tools, Establishing Facilities and most importantly developing a skilled workforce.
I am quite confident that by increasing research and innovation, the industry can focus on solutions to tackle climate change and reduce carbon emissions. Enhancing collaborations among science, technology, engineering and manufacturing sectors will strengthen domestic Bio-manufacturing. I believe this new BioE3 policy is going to put more stress on encouraging the use of advanced technologies alongside biotechnology innovations and this will promote India in Artificial Intelligence and Digital Tools. This policy will also enable the creation of Bio-manufacturing Hubs and Biofoundries to support scalable production. Above all nurturing a skilled workforce is very important. This policy stresses developing a talented workforce which is needed to drive innovation and boost the next level of the Industrial Revolution in the country.
What specific initiatives is the government implementing to foster a skill development ecosystem for startups involved in Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and bio-pharma sectors, especially in terms of adhering to sustainable environmental norms?
The government is committed to fostering a robust skill development ecosystem for startups in APIs, KSMs, and bio-pharma sectors. To achieve this goal, we are implementing several specific initiatives.
This story is from the BioSpectrum India Nov 2024 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum India Nov 2024 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.
Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research
Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.
Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data
Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.
Parse Biosciences announces expansion of Evercode BCR product line
Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.
Gene mutation likely cause for developing autism in early childhood: RGCB study
Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.
RSSDI study lays focus on Yoga and Diabetes Prevention
Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).
Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser
Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.